Nuvectis Pharma Inc. (NVCT)
NASDAQ: NVCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 20.29 0.00%
NVCT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $662.35M
- EPS (TTM)
- -$1.31
- Dividend yield
- None
- 52-week range
- 5.55 – 29.28
- Day range
- 19.67 – 20.72
- Volume / Avg
- 121.09K / 220.48K
- Beta
- —
- Shares outstanding
- 32.64M
- Next earnings
- Nov 3, 2026
52-week range
NVCT stock today
On Oct 7, NVCT ended the session at $20.29, adding $0.26 (1.30%), versus the S&P 500's 0.22% decline. Shares are 30.7% below their 52-week high of $29.28, set on Jun 29, 2026 and 265.6% above the 52-week low of $5.55, in the middle of the past year's range. NVCT is up 168.7% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 232.1%.
Nuvectis Pharma has posted a net loss over the last twelve months (EPS of -$1.31), so its P/E ratio is not meaningful. Nuvectis Pharma's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Nuvectis Pharma
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2022
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $-0.22
Nuvectis Pharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ABUSArbutus Biopharma Corporation | 4.29 | -4.24% | $657.55M | vs NVCT |
| ZVRAZevra Therapeutics Inc. | 11.08 | +3.26% | $657.97M | vs NVCT |
| FTHFaeth Therapeutics Inc. | 24.92 | -7.33% | $643.94M | vs NVCT |
| SGMTSagimet Biosciences Inc. Series A | 8.88 | +1.37% | $629.67M | vs NVCT |
| PHARPharming Group N.V. ADS | 9.65 | -0.31% | $683.01M | vs NVCT |
| IRWDIronwood Pharmaceuticals Inc. Class A | 3.75 | +3.31% | $619.65M | vs NVCT |
| CLYMClimb Bio Inc. | 10.71 | +0.28% | $615.14M | vs NVCT |
| OLMAOlema Pharmaceuticals Inc. | 7.94 | +0.25% | $694.73M | vs NVCT |
Indexes, lists and sector
Nuvectis Pharma stock FAQ
What is Nuvectis Pharma's stock price today?
NVCT last traded at $20.29 as of Oct 7, 4:00 PM EDT, up 1.30% on the day. Prices are delayed at least 15 minutes.
When is Nuvectis Pharma's next earnings date?
Nuvectis Pharma is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $-0.22.
What is the NVCT 52-week high?
The 52-week high for NVCT is $29.28 and the 52-week low is $5.55. The stock is currently 30.7% below its high.